Summary

The global Patient Recruitment for Clinical Trials market size is predicted to grow from US$ 10423 million in 2025 to US$ 18133 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.
Patient recruitment for clinical trials refers to specialized services that support the identification, screening, enrollment, and management of study participants for clinical research projects. These services typically involve multi-channel patient outreach, eligibility pre-screening, informed consent support, and enrollment tracking, enabling sponsors, CROs, and research sites to meet recruitment targets within required timelines while ensuring protocol compliance and data quality.
The market is primarily driven by the increasing number and complexity of clinical trials. Rising investment in drug development and the rapid growth of innovative therapies—such as oncology, rare diseases, biologics, and cell and gene therapies—have led to stricter inclusion/exclusion criteria and more fragmented patient populations, increasing reliance on professional recruitment services. In parallel, pressure to reduce trial timelines and costs encourages sponsors to outsource recruitment to specialized providers with data-driven and operational expertise. The adoption of digital recruitment tools, real-world data, and patient-centric engagement strategies further improves recruitment efficiency and reach, supporting continued market growth.
LPI (LP Information)' newest research report, the “Patient Recruitment for Clinical Trials Industry Forecast” looks at past sales and reviews total world Patient Recruitment for Clinical Trials sales in 2025, providing a comprehensive analysis by region and market sector of projected Patient Recruitment for Clinical Trials sales for 2026 through 2032. With Patient Recruitment for Clinical Trials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Patient Recruitment for Clinical Trials industry.
This Insight Report provides a comprehensive analysis of the global Patient Recruitment for Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Patient Recruitment for Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Patient Recruitment for Clinical Trials market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Patient Recruitment for Clinical Trials and breaks down the forecast by Clinical Trial Phase, by Therapeutic Area, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Patient Recruitment for Clinical Trials.
This report presents a comprehensive overview, market shares, and growth opportunities of Patient Recruitment for Clinical Trials market by product type, application, key players and key regions and countries.
Segmentation by Clinical Trial Phase:
Phase I
Phase II
Phase III
Phase IV
Segmentation by Client Type:
Pharmaceutical Companies
Biotechnology Companies
CROs and Research Organizations
Segmentation by Recruitment Channel:
Online
Offline
Segmentation by Therapeutic Area:
Oncology Clinical Trials
Rare Disease Clinical Trials
Chronic and Common Disease Clinical Trials
CNS and Psychiatric Clinical Trials
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Antidote
M&B Sciences
Clariness
BBK Worldwide
Worldwide Clinical Trials
American Clinical Research Services
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Trialmed
MMG
Science37
StudyKIK
Trialbee
Formation Bio
WCG Clinical Services
Trialfacts
Shanghai Jsure

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Patient Recruitment for Clinical Trials Market Size (2021-2032)
2.1.2 Patient Recruitment for Clinical Trials Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Patient Recruitment for Clinical Trials by Country/Region (2021, 2025 & 2032)
2.2 Patient Recruitment for Clinical Trials Segment by Clinical Trial Phase
2.2.1 Phase I
2.2.2 Phase II
2.2.3 Phase III
2.2.4 Phase IV
2.2.5 Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase
2.2.5.1 Patient Recruitment for Clinical Trials Market Size CAGR by Clinical Trial Phase (2021 VS 2025 VS 2032)
2.2.5.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Clinical Trial Phase (2021-2026)
2.3 Patient Recruitment for Clinical Trials Segment by Client Type
2.3.1 Pharmaceutical Companies
2.3.2 Biotechnology Companies
2.3.3 CROs and Research Organizations
2.3.4 Patient Recruitment for Clinical Trials Market Size by Client Type
2.3.4.1 Patient Recruitment for Clinical Trials Market Size CAGR by Client Type (2021 VS 2025 VS 2032)
2.3.4.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Client Type (2021-2026)
2.4 Patient Recruitment for Clinical Trials Segment by Recruitment Channel
2.4.1 Online
2.4.2 Offline
2.4.3 Patient Recruitment for Clinical Trials Market Size by Recruitment Channel
2.4.3.1 Patient Recruitment for Clinical Trials Market Size CAGR by Recruitment Channel (2021 VS 2025 VS 2032)
2.4.3.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Recruitment Channel (2021-2026)
2.5 Patient Recruitment for Clinical Trials Segment by Therapeutic Area
2.5.1 Oncology Clinical Trials
2.5.2 Rare Disease Clinical Trials
2.5.3 Chronic and Common Disease Clinical Trials
2.5.4 CNS and Psychiatric Clinical Trials
2.5.5 Others
2.5.6 Patient Recruitment for Clinical Trials Market Size by Therapeutic Area
2.5.6.1 Patient Recruitment for Clinical Trials Market Size CAGR by Therapeutic Area (2021 VS 2025 VS 2032)
2.5.6.2 Global Patient Recruitment for Clinical Trials Market Size Market Share by Therapeutic Area (2021-2026)
3 Patient Recruitment for Clinical Trials Market Size by Player
3.1 Patient Recruitment for Clinical Trials Market Size Market Share by Player
3.1.1 Global Patient Recruitment for Clinical Trials Revenue by Player (2021-2026)
3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Player (2021-2026)
3.2 Global Patient Recruitment for Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Patient Recruitment for Clinical Trials by Region
4.1 Patient Recruitment for Clinical Trials Market Size by Region (2021-2026)
4.2 Global Patient Recruitment for Clinical Trials Annual Revenue by Country/Region (2021-2026)
4.3 Americas Patient Recruitment for Clinical Trials Market Size Growth (2021-2026)
4.4 APAC Patient Recruitment for Clinical Trials Market Size Growth (2021-2026)
4.5 Europe Patient Recruitment for Clinical Trials Market Size Growth (2021-2026)
4.6 Middle East & Africa Patient Recruitment for Clinical Trials Market Size Growth (2021-2026)
5 Americas
5.1 Americas Patient Recruitment for Clinical Trials Market Size by Country (2021-2026)
5.2 Americas Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2021-2026)
5.3 Americas Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Patient Recruitment for Clinical Trials Market Size by Region (2021-2026)
6.2 APAC Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2021-2026)
6.3 APAC Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Patient Recruitment for Clinical Trials Market Size by Country (2021-2026)
7.2 Europe Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2021-2026)
7.3 Europe Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Patient Recruitment for Clinical Trials by Region (2021-2026)
8.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (2021-2026)
8.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Patient Recruitment for Clinical Trials Market Forecast
10.1 Global Patient Recruitment for Clinical Trials Forecast by Region (2027-2032)
10.1.1 Global Patient Recruitment for Clinical Trials Forecast by Region (2027-2032)
10.1.2 Americas Patient Recruitment for Clinical Trials Forecast
10.1.3 APAC Patient Recruitment for Clinical Trials Forecast
10.1.4 Europe Patient Recruitment for Clinical Trials Forecast
10.1.5 Middle East & Africa Patient Recruitment for Clinical Trials Forecast
10.2 Americas Patient Recruitment for Clinical Trials Forecast by Country (2027-2032)
10.2.1 United States Market Patient Recruitment for Clinical Trials Forecast
10.2.2 Canada Market Patient Recruitment for Clinical Trials Forecast
10.2.3 Mexico Market Patient Recruitment for Clinical Trials Forecast
10.2.4 Brazil Market Patient Recruitment for Clinical Trials Forecast
10.3 APAC Patient Recruitment for Clinical Trials Forecast by Region (2027-2032)
10.3.1 China Patient Recruitment for Clinical Trials Market Forecast
10.3.2 Japan Market Patient Recruitment for Clinical Trials Forecast
10.3.3 Korea Market Patient Recruitment for Clinical Trials Forecast
10.3.4 Southeast Asia Market Patient Recruitment for Clinical Trials Forecast
10.3.5 India Market Patient Recruitment for Clinical Trials Forecast
10.3.6 Australia Market Patient Recruitment for Clinical Trials Forecast
10.4 Europe Patient Recruitment for Clinical Trials Forecast by Country (2027-2032)
10.4.1 Germany Market Patient Recruitment for Clinical Trials Forecast
10.4.2 France Market Patient Recruitment for Clinical Trials Forecast
10.4.3 UK Market Patient Recruitment for Clinical Trials Forecast
10.4.4 Italy Market Patient Recruitment for Clinical Trials Forecast
10.4.5 Russia Market Patient Recruitment for Clinical Trials Forecast
10.5 Middle East & Africa Patient Recruitment for Clinical Trials Forecast by Region (2027-2032)
10.5.1 Egypt Market Patient Recruitment for Clinical Trials Forecast
10.5.2 South Africa Market Patient Recruitment for Clinical Trials Forecast
10.5.3 Israel Market Patient Recruitment for Clinical Trials Forecast
10.5.4 Turkey Market Patient Recruitment for Clinical Trials Forecast
10.6 Global Patient Recruitment for Clinical Trials Forecast by Clinical Trial Phase (2027-2032)
10.7 Global Patient Recruitment for Clinical Trials Forecast by Therapeutic Area (2027-2032)
10.7.1 GCC Countries Market Patient Recruitment for Clinical Trials Forecast
11 Key Players Analysis
11.1 Antidote
11.1.1 Antidote Company Information
11.1.2 Antidote Patient Recruitment for Clinical Trials Product Offered
11.1.3 Antidote Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Antidote Main Business Overview
11.1.5 Antidote Latest Developments
11.2 M&B Sciences
11.2.1 M&B Sciences Company Information
11.2.2 M&B Sciences Patient Recruitment for Clinical Trials Product Offered
11.2.3 M&B Sciences Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 M&B Sciences Main Business Overview
11.2.5 M&B Sciences Latest Developments
11.3 Clariness
11.3.1 Clariness Company Information
11.3.2 Clariness Patient Recruitment for Clinical Trials Product Offered
11.3.3 Clariness Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Clariness Main Business Overview
11.3.5 Clariness Latest Developments
11.4 BBK Worldwide
11.4.1 BBK Worldwide Company Information
11.4.2 BBK Worldwide Patient Recruitment for Clinical Trials Product Offered
11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 BBK Worldwide Main Business Overview
11.4.5 BBK Worldwide Latest Developments
11.5 Worldwide Clinical Trials
11.5.1 Worldwide Clinical Trials Company Information
11.5.2 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product Offered
11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Worldwide Clinical Trials Main Business Overview
11.5.5 Worldwide Clinical Trials Latest Developments
11.6 American Clinical Research Services
11.6.1 American Clinical Research Services Company Information
11.6.2 American Clinical Research Services Patient Recruitment for Clinical Trials Product Offered
11.6.3 American Clinical Research Services Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 American Clinical Research Services Main Business Overview
11.6.5 American Clinical Research Services Latest Developments
11.7 IQVIA
11.7.1 IQVIA Company Information
11.7.2 IQVIA Patient Recruitment for Clinical Trials Product Offered
11.7.3 IQVIA Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 IQVIA Main Business Overview
11.7.5 IQVIA Latest Developments
11.8 PPD Inc
11.8.1 PPD Inc Company Information
11.8.2 PPD Inc Patient Recruitment for Clinical Trials Product Offered
11.8.3 PPD Inc Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 PPD Inc Main Business Overview
11.8.5 PPD Inc Latest Developments
11.9 Veristat
11.9.1 Veristat Company Information
11.9.2 Veristat Patient Recruitment for Clinical Trials Product Offered
11.9.3 Veristat Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Veristat Main Business Overview
11.9.5 Veristat Latest Developments
11.10 Elligo Health Research
11.10.1 Elligo Health Research Company Information
11.10.2 Elligo Health Research Patient Recruitment for Clinical Trials Product Offered
11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Elligo Health Research Main Business Overview
11.10.5 Elligo Health Research Latest Developments
11.11 AutoCruitment
11.11.1 AutoCruitment Company Information
11.11.2 AutoCruitment Patient Recruitment for Clinical Trials Product Offered
11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 AutoCruitment Main Business Overview
11.11.5 AutoCruitment Latest Developments
11.12 Clinical Connection
11.12.1 Clinical Connection Company Information
11.12.2 Clinical Connection Patient Recruitment for Clinical Trials Product Offered
11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Clinical Connection Main Business Overview
11.12.5 Clinical Connection Latest Developments
11.13 Biorasi
11.13.1 Biorasi Company Information
11.13.2 Biorasi Patient Recruitment for Clinical Trials Product Offered
11.13.3 Biorasi Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biorasi Main Business Overview
11.13.5 Biorasi Latest Developments
11.14 Curavit Clinical Research
11.14.1 Curavit Clinical Research Company Information
11.14.2 Curavit Clinical Research Patient Recruitment for Clinical Trials Product Offered
11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Curavit Clinical Research Main Business Overview
11.14.5 Curavit Clinical Research Latest Developments
11.15 PatientEvolution
11.15.1 PatientEvolution Company Information
11.15.2 PatientEvolution Patient Recruitment for Clinical Trials Product Offered
11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 PatientEvolution Main Business Overview
11.15.5 PatientEvolution Latest Developments
11.16 Trialmed
11.16.1 Trialmed Company Information
11.16.2 Trialmed Patient Recruitment for Clinical Trials Product Offered
11.16.3 Trialmed Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Trialmed Main Business Overview
11.16.5 Trialmed Latest Developments
11.17 MMG
11.17.1 MMG Company Information
11.17.2 MMG Patient Recruitment for Clinical Trials Product Offered
11.17.3 MMG Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 MMG Main Business Overview
11.17.5 MMG Latest Developments
11.18 Science37
11.18.1 Science37 Company Information
11.18.2 Science37 Patient Recruitment for Clinical Trials Product Offered
11.18.3 Science37 Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Science37 Main Business Overview
11.18.5 Science37 Latest Developments
11.19 StudyKIK
11.19.1 StudyKIK Company Information
11.19.2 StudyKIK Patient Recruitment for Clinical Trials Product Offered
11.19.3 StudyKIK Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 StudyKIK Main Business Overview
11.19.5 StudyKIK Latest Developments
11.20 Trialbee
11.20.1 Trialbee Company Information
11.20.2 Trialbee Patient Recruitment for Clinical Trials Product Offered
11.20.3 Trialbee Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Trialbee Main Business Overview
11.20.5 Trialbee Latest Developments
11.21 Formation Bio
11.21.1 Formation Bio Company Information
11.21.2 Formation Bio Patient Recruitment for Clinical Trials Product Offered
11.21.3 Formation Bio Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Formation Bio Main Business Overview
11.21.5 Formation Bio Latest Developments
11.22 WCG Clinical Services
11.22.1 WCG Clinical Services Company Information
11.22.2 WCG Clinical Services Patient Recruitment for Clinical Trials Product Offered
11.22.3 WCG Clinical Services Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 WCG Clinical Services Main Business Overview
11.22.5 WCG Clinical Services Latest Developments
11.23 Trialfacts
11.23.1 Trialfacts Company Information
11.23.2 Trialfacts Patient Recruitment for Clinical Trials Product Offered
11.23.3 Trialfacts Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Trialfacts Main Business Overview
11.23.5 Trialfacts Latest Developments
11.24 Shanghai Jsure
11.24.1 Shanghai Jsure Company Information
11.24.2 Shanghai Jsure Patient Recruitment for Clinical Trials Product Offered
11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Shanghai Jsure Main Business Overview
11.24.5 Shanghai Jsure Latest Developments
12 Research Findings and Conclusion